Helius Medical Technologies Inc (HSDT)

$21.35 +3.08 (16.86%)
Market Cap 8.14M
Revenue (ttm) 520,000.00
Net Income (ttm) -11.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,257.69%
Debt to Equity Ratio 0.00
Volume 1,254,714
Avg Vol 830,816
Day's Range N/A - N/A
Shares Out 1.08M
Stochastic %K 67%
Beta 0.74
Analysts Hold
Price Target $4.00

Company Profile

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in c...

Industry: Medical Devices
Sector: Healthcare
Phone: 215 944 6100
Address:
642 Newtown Yardley Road, Suite 100, Newtown, United States
Phazzatrades
Phazzatrades Sep. 16 at 5:36 PM
$HSDT knocking on the door, will we be invited in?
0 · Reply
Peter__North
Peter__North Sep. 16 at 5:34 PM
$HSDT on everyone's scanners on a red day for the overall markets at lunch. Imagine what power hour will bring!
0 · Reply
Jonita
Jonita Sep. 16 at 5:05 PM
$HSDT in
0 · Reply
ProfessorDman1
ProfessorDman1 Sep. 16 at 4:57 PM
Swing analysis on $HSDT $7S channel and ran $52 yesterday 💵💵💵 Now I’m focusing on $SLRX next double digit runner here
1 · Reply
dln101
dln101 Sep. 16 at 4:50 PM
$ADIL low float bio has great news today, should start bouncing like $HBIO $CHEK $HSDT 🤔💪🔥🚀 https://www.tradingview.com/news/reuters.com,2025:newsml_TUABHJV6N:0-adial-pharma-provides-updates-after-fda-s-favorable-eop2-feedback-on-ad04-for-alcohol-use-disorder-treatment/
0 · Reply
KittyCat888
KittyCat888 Sep. 16 at 4:50 PM
$HSDT keep running baby, your pace hasn't changed since yesterday 🏃‍♂️
0 · Reply
Tradingistheway
Tradingistheway Sep. 16 at 4:38 PM
$HSDT called $100 it’s coming
0 · Reply
_www_larval_com_
_www_larval_com_ Sep. 16 at 4:32 PM
$HSDT has reverted -6% lower to 10% (~1Mv) in the last few minutes, follow for more volatility.
0 · Reply
WavyTraders
WavyTraders Sep. 16 at 4:29 PM
$HSDT run it
0 · Reply
Phazzatrades
Phazzatrades Sep. 16 at 4:19 PM
$HSDT this has held up all day, let’s rock 17:30 👏🏼
0 · Reply
Latest News on HSDT
Inside Helius Medical's $500 Million Raise — And Its Solana Treasury Plans

Sep 15, 2025, 12:21 PM EDT - 1 day ago

Inside Helius Medical's $500 Million Raise — And Its Solana Treasury Plans

Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company

Sep 15, 2025, 8:10 AM EDT - 1 day ago

Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

Jul 21, 2025, 7:00 AM EDT - 2 months ago

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements

Jul 9, 2025, 8:30 AM EDT - 2 months ago

Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements

Helius Medical Technologies, Sunrun And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Jul 8, 2025, 8:01 AM EDT - 2 months ago

Helius Medical Technologies, Sunrun And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

RUN

Helius Medical Technologies Announces Reverse Stock Split

Jun 27, 2025, 8:30 AM EDT - 2 months ago

Helius Medical Technologies Announces Reverse Stock Split

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device

Jun 16, 2025, 7:00 AM EDT - 3 months ago

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

Jun 12, 2025, 7:00 AM EDT - 3 months ago

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

Jun 11, 2025, 7:00 AM EDT - 3 months ago

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering

Jun 4, 2025, 9:12 PM EDT - 3 months ago

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering

Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria

Jun 4, 2025, 7:00 AM EDT - 3 months ago

Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

May 20, 2025, 7:00 AM EDT - 4 months ago

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

May 12, 2025, 7:00 AM EDT - 4 months ago

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary

Mar 13, 2025, 7:00 AM EDT - 6 months ago

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Mar 11, 2025, 7:00 AM EDT - 6 months ago

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Jan 22, 2025, 7:00 AM EST - 8 months ago

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

Jan 21, 2025, 8:00 PM EST - 8 months ago

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

Dec 23, 2024, 7:00 AM EST - 9 months ago

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Nov 18, 2024, 8:01 AM EST - 10 months ago

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Oct 14, 2024, 5:00 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Aug 16, 2024, 5:00 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 9:33 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results

Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024

Aug 6, 2024, 4:36 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024

Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke

Jun 17, 2024, 7:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke

Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference

May 31, 2024, 12:30 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference

Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

May 23, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

May 20, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

Helius Medical Technologies, Inc. (HSDT) Q1 2024 Earnings Call Transcript

May 13, 2024, 7:21 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q1 2024 Earnings Call Transcript

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

May 13, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

May 10, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

May 6, 2024, 10:15 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Apr 24, 2024, 9:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Helius Medical stock rallies 40%: explore why

Apr 3, 2024, 7:55 AM EDT - 1 year ago

Helius Medical stock rallies 40%: explore why

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

Apr 3, 2024, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 8:45 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

Mar 15, 2024, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

Mar 12, 2024, 8:59 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

Mar 7, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Mar 4, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

Feb 6, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists' Ability to Customize PoNS Therapy® to Improve Gait in People with MS

Feb 5, 2024, 7:05 AM EST - 1 year ago

Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists' Ability to Customize PoNS Therapy® to Improve Gait in People with MS

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Jan 11, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Helius Medical Technologies to Present at NobleCon19 Annual Conference

Nov 30, 2023, 7:47 AM EST - 1 year ago

Helius Medical Technologies to Present at NobleCon19 Annual Conference

Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript

Nov 12, 2023, 8:11 AM EST - 2 years ago

Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

Nov 6, 2023, 7:05 AM EST - 2 years ago

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

Nov 2, 2023, 5:05 PM EDT - 2 years ago

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices

Oct 12, 2023, 7:05 AM EDT - 2 years ago

Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

Oct 2, 2023, 7:05 AM EDT - 2 years ago

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

Phazzatrades
Phazzatrades Sep. 16 at 5:36 PM
$HSDT knocking on the door, will we be invited in?
0 · Reply
Peter__North
Peter__North Sep. 16 at 5:34 PM
$HSDT on everyone's scanners on a red day for the overall markets at lunch. Imagine what power hour will bring!
0 · Reply
Jonita
Jonita Sep. 16 at 5:05 PM
$HSDT in
0 · Reply
ProfessorDman1
ProfessorDman1 Sep. 16 at 4:57 PM
Swing analysis on $HSDT $7S channel and ran $52 yesterday 💵💵💵 Now I’m focusing on $SLRX next double digit runner here
1 · Reply
dln101
dln101 Sep. 16 at 4:50 PM
$ADIL low float bio has great news today, should start bouncing like $HBIO $CHEK $HSDT 🤔💪🔥🚀 https://www.tradingview.com/news/reuters.com,2025:newsml_TUABHJV6N:0-adial-pharma-provides-updates-after-fda-s-favorable-eop2-feedback-on-ad04-for-alcohol-use-disorder-treatment/
0 · Reply
KittyCat888
KittyCat888 Sep. 16 at 4:50 PM
$HSDT keep running baby, your pace hasn't changed since yesterday 🏃‍♂️
0 · Reply
Tradingistheway
Tradingistheway Sep. 16 at 4:38 PM
$HSDT called $100 it’s coming
0 · Reply
_www_larval_com_
_www_larval_com_ Sep. 16 at 4:32 PM
$HSDT has reverted -6% lower to 10% (~1Mv) in the last few minutes, follow for more volatility.
0 · Reply
WavyTraders
WavyTraders Sep. 16 at 4:29 PM
$HSDT run it
0 · Reply
Phazzatrades
Phazzatrades Sep. 16 at 4:19 PM
$HSDT this has held up all day, let’s rock 17:30 👏🏼
0 · Reply
Lambomojo
Lambomojo Sep. 16 at 4:18 PM
$HSDT I'm not selling until it reaches $40, like $DFDV $SBET $BMNR $ETHX.X did
1 · Reply
My_Dog_Sam
My_Dog_Sam Sep. 16 at 4:16 PM
$HSDT LET’S GOOOOOOOO!! 💎💎💎
0 · Reply
Phazzatrades
Phazzatrades Sep. 16 at 4:12 PM
$HSDT patience 🤑
0 · Reply
gradeAsetup
gradeAsetup Sep. 16 at 4:06 PM
$HSDT shorts are really trapped now
0 · Reply
sammed
sammed Sep. 16 at 4:01 PM
$HSDT getting ready for next leg
0 · Reply
caliphonegear
caliphonegear Sep. 16 at 4:00 PM
$HSDT is my next cash cow
0 · Reply
My_Dog_Sam
My_Dog_Sam Sep. 16 at 3:38 PM
$HSDT
0 · Reply
Joby099
Joby099 Sep. 16 at 3:30 PM
$HSDT
0 · Reply
Tradingistheway
Tradingistheway Sep. 16 at 3:29 PM
$HSDT only have 2 stocks $NUAI
0 · Reply
Invartis
Invartis Sep. 16 at 3:26 PM
$HSDT down 96.9% in 1 year and that's after this pump...and this is the trend year after year. Can this management just quit fiddling with that basically useless PoNS thing and stop burning investors money? If you're in this for some time you should tell management about that. This stock has never failed to find new lows going fwd.
0 · Reply
Peter__North
Peter__North Sep. 16 at 3:22 PM
$HSDT $SOL.X is the rare equity that is green today, so the tailwinds are at our backs.
0 · Reply
Mysteryman123
Mysteryman123 Sep. 16 at 3:13 PM
$HSDT Whoever sells here his helping people like this guy to make money.. Hold and fight against evil
0 · Reply